Skip to search.
 TSX Up 0.40% TSX Ventures Down 1.68%

Titan Pharmaceuticals Inc. (TTNP)

-NasdaqCM
6.86 Down 0.21(2.97%) May 27, 4:00PM EDT
Prev Close:7.07
Open:8.51
Bid:6.96 x 4600
Ask:6.98 x 400
1y Target Est:10.00
Beta:1.53197
Earnings Date:Aug 11 - Aug 15 (Est.)
Day's Range:6.61 - 8.74
52wk Range:2.57 - 10.00
Volume:9,425,864
Avg Vol (3m):429,577
Market Cap:137.78M
P/E (ttm):N/A
EPS (ttm):-0.41
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
TTNPDown 2.97%137.78M
LLYDown 0.70%79.13B
PFEUp 0.52%209.90B
JNJUp 0.14%310.99B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):186.83
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :0.28
Quarterly EPS Est (Jun-16) :0.56
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Titan Pharmaceuticals, Inc., a specialty pharmaceutical company, develops proprietary therapeutics for the treatment of serious medical disorders in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback